149 related articles for article (PubMed ID: 21608142)
1. High-pressure refolding of human vascular endothelial growth factor (VEGF) recombinantly expressed in bacterial inclusion bodies: refolding optimization, and feasibility assessment.
Cothran A; St John RJ; Schmelzer CH; Pizarro SA
Biotechnol Prog; 2011; 27(5):1273-81. PubMed ID: 21608142
[TBL] [Abstract][Full Text] [Related]
2. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
3. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
4. Use of the design-of-experiments approach for the development of a refolding technology for progenipoietin-1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies.
Boyle DM; Buckley JJ; Johnson GV; Rathore A; Gustafson ME
Biotechnol Appl Biochem; 2009 Jul; 54(2):85-92. PubMed ID: 19435462
[TBL] [Abstract][Full Text] [Related]
5. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography.
Chen Y; Leong SS
J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725
[TBL] [Abstract][Full Text] [Related]
6. Prokaryotic expression, refolding, and purification of functional human vascular endothelial growth factor isoform 165: purification procedures and refolding conditions revisited.
Lee IL; Li PS; Yu WL; Shen HH
Protein Expr Purif; 2011 Mar; 76(1):54-8. PubMed ID: 20826215
[TBL] [Abstract][Full Text] [Related]
7. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
[TBL] [Abstract][Full Text] [Related]
8. Confronting high-throughput protein refolding using high pressure and solution screens.
Qoronfleh MW; Hesterberg LK; Seefeldt MB
Protein Expr Purif; 2007 Oct; 55(2):209-24. PubMed ID: 17681810
[TBL] [Abstract][Full Text] [Related]
9. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of rhNTA protein by chromatography.
Fan X; Xu D; Lu B; Xia J; Wei D
Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting protein refolding yields in a fed-batch and batch-refolding system.
Mannall GJ; Titchener-Hooker NJ; Dalby PA
Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557
[TBL] [Abstract][Full Text] [Related]
12. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
Wang C; Wang L; Geng X
Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
[TBL] [Abstract][Full Text] [Related]
13. Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study.
Singh SM; Eshwari AN; Garg LC; Panda AK
Methods Mol Biol; 2005; 308():163-76. PubMed ID: 16082034
[No Abstract] [Full Text] [Related]
14. Technical refolding of proteins: Do we have freedom to operate?
Eiberle MK; Jungbauer A
Biotechnol J; 2010 Jun; 5(6):547-59. PubMed ID: 20518058
[TBL] [Abstract][Full Text] [Related]
15. Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis.
Chura-Chambi RM; Nakajima E; de Carvalho RR; Miyasato PA; Oliveira SC; Morganti L; Martins EA
J Biotechnol; 2013 Dec; 168(4):511-9. PubMed ID: 24084635
[TBL] [Abstract][Full Text] [Related]
16. Practical applications of hydrostatic pressure to refold proteins from inclusion bodies for NMR structural studies.
Ogura K; Kobashigawa Y; Saio T; Kumeta H; Torikai S; Inagaki F
Protein Eng Des Sel; 2013 Jun; 26(6):409-16. PubMed ID: 23525046
[TBL] [Abstract][Full Text] [Related]
17. Expression, refolding, and characterization of a novel recombinant dual human stem cell factor.
Lu H; Zang Y; Ze Y; Zhu J; Chen T; Han J; Qin J
Protein Expr Purif; 2005 Oct; 43(2):126-32. PubMed ID: 16139754
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions.
Dechavanne V; Barrillat N; Borlat F; Hermant A; Magnenat L; Paquet M; Antonsson B; Chevalet L
Protein Expr Purif; 2011 Feb; 75(2):192-203. PubMed ID: 20851186
[TBL] [Abstract][Full Text] [Related]
19. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
Misawa S; Kumagai I
Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
[TBL] [Abstract][Full Text] [Related]
20. Anti-aggregatory effect of cyclodextrins in the refolding process of recombinant growth hormones from Escherichia coli inclusion bodies.
Bajorunaite E; Cirkovas A; Radzevicius K; Larsen KL; Sereikaite J; Bumelis VA
Int J Biol Macromol; 2009 Jun; 44(5):428-34. PubMed ID: 19428477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
